Ceretype Neuromedicine, Inc.

📍 Cambridge, United States🗓 Founded 2020👥 5 employees💰 Last funded Mar 2022
Biotechnology🌐 ceretype.com
Website LinkedIn
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Ceretype Neuromedicine, Inc.?
Ceretype Neuromedicine, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Ceretype Neuromedicine, Inc. last raise funding?
The most recent investment in Ceretype Neuromedicine, Inc. recorded on gritt.io was in March 2022.
When was Ceretype Neuromedicine, Inc. founded?
Ceretype Neuromedicine, Inc. was founded in 2020.
What industry is Ceretype Neuromedicine, Inc. in?
Ceretype Neuromedicine, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Ceretype Neuromedicine, Inc. based?
Ceretype Neuromedicine, Inc. is headquartered in Cambridge, United States.